Q9H7Z7 (PGES2_HUMAN) Reviewed, UniProtKB/Swiss-Prot
Last modified
May 1, 2013.
Version 113.
History...
Names·Attributes·General annotation·Ontologies·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: Prostaglandin E synthase 2 EC=5.3.99.3 Alternative name(s): Microsomal prostaglandin E synthase 2 Short name=mPGES-2 Cleaved into the following chain: | ||||
| Gene names |
| ||||
| Organism | Homo sapiens (Human) [Reference proteome] | ||||
| Taxonomic identifier | 9606 [NCBI] | ||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo![]() |
Protein attributes
| Sequence length | 377 AA. |
| Sequence status | Complete. |
| Sequence processing | The displayed sequence is further processed into a mature form. |
| Protein existence | Evidence at protein level |
General annotation (Comments)
| Function | Isomerase that catalyzes the conversion of unstable intermediate of prostaglandin E2 H2 (PGH2) into the more stable prostaglandin E2 (PGE2) form. May also have transactivation activity toward IFN-gamma (IFNG), possibly via an interaction with CEBPB; however, the relevance of transcription activation activity remains unclear. |
| Catalytic activity | (5Z,13E)-(15S)-9-alpha,11-alpha-epidioxy-15-hydroxyprosta-5,13-dienoate = (5Z,13E)-(15S)-11-alpha,15-dihydroxy-9-oxoprosta-5,13-dienoate. |
| Cofactor | Dihydrolipoic acid. Ref.6 |
| Pathway | |
| Subunit structure | Homodimer. May interact with CEBPB By similarity. Interacts with EXOSC10. Ref.8 |
| Subcellular location | Golgi apparatus membrane; Single-pass membrane protein Ref.7. Prostaglandin E synthase 2 truncated form: Cytoplasm › perinuclear region. Note: Synthetized as a Golgi membrane-bound protein, which is further cleaved into the predominant soluble truncated form. The truncated form is cytoplasmic and is enriched in the perinuclear region. Ref.7 |
| Tissue specificity | Widely expressed. Expressed in the heart, including apex, inter-ventricular septum, both atria and ventricles, but not in the aorta. Also expressed in fetal heart. Detected in various regions of the brain: cerebellum; occipital, frontal and parietal lobes. Also expressed in the lymph nodes, skeletal muscle, kidney and trachea, but not in the thymus or lung. Overexpressed in colorectal cancer. Ref.5 |
| Sequence similarities | Belongs to the GST superfamily. Contains 1 glutaredoxin domain. Contains 1 GST C-terminal domain. |
| Sequence caution | The sequence CAI13822.1 differs from that shown. Reason: Erroneous gene model prediction. |
Ontologies
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||
Molecule processing | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Chain | 1 – 377 | 377 | Prostaglandin E synthase 2 | PRO_0000013127 | |||||
| Chain | 88 – 377 | 290 | Prostaglandin E synthase 2 truncated form By similarity | PRO_0000013128 | |||||
Regions | |||||||||
| Topological domain | 1 – 57 | 57 | Lumenal Potential | ||||||
| Transmembrane | 58 – 74 | 17 | Helical; Potential | ||||||
| Topological domain | 75 – 377 | 303 | Cytoplasmic Potential | ||||||
| Domain | 90 – 193 | 104 | Glutaredoxin | ||||||
| Domain | 263 – 377 | 115 | GST C-terminal | ||||||
| Region | 164 – 165 | 2 | Glutathione binding By similarity | ||||||
Sites | |||||||||
| Binding site | 148 | 1 | Glutathione; via amide nitrogen and carbonyl oxygen By similarity | ||||||
| Site | 87 – 88 | 2 | Cleavage By similarity | ||||||
Natural variations | |||||||||
| Natural variant | 298 | 1 | R → H. Corresponds to variant rs13283456 [ dbSNP | Ensembl ]. | VAR_049494 | |||||
Experimental info | |||||||||
| Mutagenesis | 110 | 1 | C → S: Loss of function. Ref.6 | ||||||
| Mutagenesis | 113 | 1 | C → S: Does not strongly affect enzyme activity. Ref.6 | ||||||
| Sequence conflict | 319 | 1 | G → S in BAD97240. Ref.2 | ||||||
Sequences
| ||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "Complete sequencing and characterization of 21,243 full-length human cDNAs." Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R., Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H., Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S. Sugano S.Nat. Genet. 36:40-45(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. Tissue: Embryo. |
| [2] | Totoki Y., Toyoda A., Takeda T., Sakaki Y., Tanaka A., Yokoyama S. Submitted (APR-2005) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. |
| [3] | "DNA sequence and analysis of human chromosome 9." Humphray S.J., Oliver K., Hunt A.R., Plumb R.W., Loveland J.E., Howe K.L., Andrews T.D., Searle S., Hunt S.E., Scott C.E., Jones M.C., Ainscough R., Almeida J.P., Ambrose K.D., Ashwell R.I.S., Babbage A.K., Babbage S., Bagguley C.L. Dunham I.Nature 429:369-374(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [4] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. Tissue: Brain and Lung. |
| [5] | "Identification and characterization of a novel type of membrane-associated prostaglandin E synthase." Tanikawa N., Ohmiya Y., Ohkubo H., Hashimoto K., Kangawa K., Kojima M., Ito S., Watanabe K. Biochem. Biophys. Res. Commun. 291:884-889(2002) [PubMed] [Europe PMC] [Abstract] Cited for: TISSUE SPECIFICITY. |
| [6] | "Essential 110Cys in active site of membrane-associated prostaglandin E synthase-2." Watanabe K., Ohkubo H., Niwa H., Tanikawa N., Koda N., Ito S., Ohmiya Y. Biochem. Biophys. Res. Commun. 306:577-581(2003) [PubMed] [Europe PMC] [Abstract] Cited for: COFACTOR, MUTAGENESIS OF CYS-110 AND CYS-113. |
| [7] | "Cellular prostaglandin E2 production by membrane-bound prostaglandin E synthase-2 via both cyclooxygenases-1 and -2." Murakami M., Nakashima K., Kamei D., Masuda S., Ishikawa Y., Ishii T., Ohmiya Y., Watanabe K., Kudo I. J. Biol. Chem. 278:37937-37947(2003) [PubMed] [Europe PMC] [Abstract] Cited for: CLEAVAGE, SUBCELLULAR LOCATION. |
| [8] | "A protein interaction framework for human mRNA degradation." Lehner B., Sanderson C.M. Genome Res. 14:1315-1323(2004) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH EXOSC10. |
| [9] | "Initial characterization of the human central proteome." Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J. BMC Syst. Biol. 5:17-17(2011) [PubMed] [Europe PMC] [Abstract] Cited for: IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |
|---|---|
| EMBL GenBank DDBJ | AK024100 mRNA. Translation: BAB14826.1. AK223520 mRNA. Translation: BAD97240.1. AL590708 Genomic DNA. Translation: CAI13821.1. AL590708 Genomic DNA. Translation: CAI13822.1. Sequence problems. BC009397 mRNA. Translation: AAH09397.2. BC009456 mRNA. Translation: AAH09456.1. BC011613 mRNA. Translation: AAH11613.1. |
| IPI | IPI00303568. |
| RefSeq | NP_001243264.1. NM_001256335.1. NP_079348.1. NM_025072.6. NP_945176.1. NM_198938.2. |
| UniGene | Hs.495219. |
3D structure databases | |
| ProteinModelPortal | Q9H7Z7. |
| ModBase | Search... |
Protein-protein interaction databases | |
| IntAct | Q9H7Z7. 6 interactions. |
| STRING | 9606.ENSP00000345341. |
PTM databases | |
| PhosphoSite | Q9H7Z7. |
Polymorphism databases | |
| DMDM | 73921741. |
Proteomic databases | |
| PaxDb | Q9H7Z7. |
| PRIDE | Q9H7Z7. |
Protocols and materials databases | |
| DNASU | 80142. |
| StructuralBiologyKnowledgebase | Search... |
Genome annotation databases | |
| Ensembl | ENST00000338961; ENSP00000345341; ENSG00000148334. ENST00000449878; ENSP00000411378; ENSG00000148334. |
| GeneID | 80142. |
| KEGG | hsa:80142. |
| UCSC | uc004bti.3. human. |
Organism-specific databases | |
| CTD | 80142. |
| GeneCards | GC09M130882. |
| HGNC | HGNC:17822. PTGES2. |
| HPA | HPA020631. |
| MIM | 608152. gene. |
| neXtProt | NX_Q9H7Z7. |
| PharmGKB | PA33949. |
| GenAtlas | Search... |
Phylogenomic databases | |
| eggNOG | NOG316980. |
| HOGENOM | HOG000231901. |
| HOVERGEN | HBG069136. |
| InParanoid | Q9H7Z7. |
| KO | K05309. |
| OMA | AMYFISK. |
| OrthoDB | EOG4R7VB3. |
Enzyme and pathway databases | |
| BRENDA | 5.3.99.3. 2681. |
| Pathway_Interaction_DB | ifngpathway. IFN-gamma pathway. |
| UniPathway | UPA00662. |
Gene expression databases | |
| ArrayExpress | Q9H7Z7. |
| Bgee | Q9H7Z7. |
| CleanEx | HS_PTGES2. |
| Genevestigator | Q9H7Z7. |
| GermOnline | ENSG00000148334. Homo sapiens. |
Family and domain databases | |
| Gene3D | 1.20.1050.10. 2 hits. 3.40.30.10. 1 hit. |
| InterPro | IPR002109. Glutaredoxin. IPR010987. Glutathione-S-Trfase_C-like. IPR017933. Glutathione_S_Trfase/Cl_chnl_C. IPR004046. GST_C. IPR012336. Thioredoxin-like_fold. [Graphical view] |
| Pfam | PF00043. GST_C. 1 hit. [Graphical view] |
| SUPFAM | SSF47616. GST_C_like. 1 hit. SSF52833. Thiordxn-like_fd. 1 hit. |
| PROSITE | PS00195. GLUTAREDOXIN_1. 1 hit. PS51354. GLUTAREDOXIN_2. 1 hit. PS50405. GST_CTER. 1 hit. [Graphical view] |
| ProtoNet | Search... |
Other | |
| BindingDB | Q9H7Z7. |
| ChEMBL | CHEMBL4411. |
| ChiTaRS | PTGES2. human. |
| GenomeRNAi | 80142. |
| NextBio | 70401. |
| SOURCE | Search... |
Entry information
| Entry name | PGES2_HUMAN | ||||||||
| Accession | Primary (citable) accession number: Q9H7Z7 Secondary accession number(s): Q53EW9 Q96GL2 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Chordata Protein Annotation Program | ||||||||
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | ||||||||
Relevant documents
| Human chromosome 9 Human chromosome 9: entries, gene names and cross-references to MIM |
| Human entries with polymorphisms or disease mutations List of human entries with polymorphisms or disease mutations |
| Human polymorphisms and disease mutations Index of human polymorphisms and disease mutations |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |
| PATHWAY comments Index of metabolic and biosynthesis pathways |
| SIMILARITY comments Index of protein domains and families |

Clusters with
